Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04098809 · ClinicalTrials.gov registry record · NA

Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy

A NA study of Prostate Cancer, sponsored by Benaroya Research Institute.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT04098809 is a NA study of Prostate Cancer that has completed, run by Benaroya Research Institute. The registered enrollment target is 52 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04098809, a NA study of Prostate Cancer, has completed, sponsored by Benaroya Research Institute.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

This study is designed to assess the effect of catheter size on postoperative catheter pain, urinary continence, urinary flow rates, post void residuals, International Prostate Symptom Scores (IPSS), and Quality of Life (QoL) score, as well as long term complications after robotic assisted laparoscopic prostatectomy.

Conditions Studied

Interventions

  • DEVICE 16 French urinary catheter
  • DEVICE 20 French urinary catheter

Study Locations (1)

Washington

  • Virginia Mason Medical center - Seattle

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2017-11-09
Est. Completion 2018-11-07
Phase NA

Sponsor

Benaroya Research Institute

28 total trials

What the Registry Record Tells You About NCT04098809

The ClinicalTrials.gov registry entry for NCT04098809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Benaroya Research Institute, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which 16 French urinary catheter is the first listed.

NCT04098809 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04098809 about?

NCT04098809 is a clinical study titled "Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy". This study is designed to assess the effect of catheter size on postoperative catheter pain, urinary continence, urinary flow rates, post void residuals, International Prostate Symptom Scores (IPSS), and Quality of Life (QoL) score, as well as long term complications after robotic assisted laparosco...

What is the current status of trial NCT04098809?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2017-11-09. Estimated completion is 2018-11-07.

What conditions does trial NCT04098809 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04098809?

The interventions under investigation include: 16 French urinary catheter (DEVICE), 20 French urinary catheter (DEVICE).

Who is sponsoring clinical trial NCT04098809?

This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04098809 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.